About this episode
Another most enjoyable webinar from our friends at the Prostate Cancer Foundation, this time focussing on the TheraP trial recently presented at #ASCO20, a randomised trial of Lu-PSMA vs cabazitaxel in progressive mCRPC. Professor Michael Hofman presents the data and is joined by an esteemed global panel including Professor Ian Davis, Professor Cora Sternberg and Professor Wolfgang Weber. Co-hosted by Professor Declan Murphy and Dr Howard Soule. More than 500 registrants from over 40 countries joined in, many of whom contributed to a very lively discussion. Enjoy!
Get every episode summarized
Each time GU Cast | Urology Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from GU Cast | Urology Podcast
Is Copper the new Gold??! Co-PSMA trial in European Urology
GU Cast | Urology Podcast
EAU Prostate Cancer Guideline Update
GU Cast | Urology Podcast
Journal club #7 | proPSMA and Penile Fractures(!)
GU Cast | Urology Podcast
ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari
GU Cast | Urology Podcast